Abstract-[3H]8-OH-DPATbinding to rat brain sections and inhibition by SM 3997 were investigated.Very high densities of [3H]8-OH-DPAT binding sites were found in the dentate gyrus, entorhinal cortex, dorsal raphe, interpeduncular nucleus and lateral septum.In contrast, their densities were sparse in the sub stantia nigra, caudate putamen and choroid plexus.In the presence of 1 ,aM of SM-3997, [3H]8-OH-DPAT binding was strongly inhibited in all the brain structures we examined.These results indicate that SM-3997 binds to 5-HT,' receptors of rat brain sections.
Benzodiazepines(BZs) are widely used as therapeutic drugs for anxiety, but often pro duce undesirable side effects such as drow siness, ataxia and sedation. These agents bind to BZ receptor sites of GABA receptor/Cl channel complexes and modulate GABAergic functions. This GABA-related mechanism is considered to mediate not only the anxiolytic effect but also other side effects of BZs.SM-3997 (3aa,48,78,7aa-hexahydro-2 (4 (4 (2-pyrimidinyl)-1-piperazinyl)-butyl) 4,7 methano -1 H isoindole -1,3(2H) dione dihydrogen citrate) is a clinically effective anxiolytic that is devoid of these side effects. We previously reported that SM-3997 did not directly interact with GABA receptor/CI channel complexes, but is suggested to have 5-HT1A agonistic properties by pharmacolo gical, biochemical and electrophysiological experiments (1-5). The present study was conducted to determine the regional distribu tion of 5-HT,,, receptors and SM-3997 binding to these receptors in the rat brain.Male Sprague-Dawley rats (weighing about 300 g) were decapitated, and the brains were quickly frozen. 8-OH-DPAT has been shown to selectively interact with 5-HT1A receptors (7), so we used this ligand to label this receptor subtype. The autoradiographic localization of specific [3H] 8-OH-DPAT binding sites in the rat brain sec tions are shown in Fig. 1 A and